5 HT₃-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalitiesQURAISHI, Sadeq A; SCHULER, Gregg H; JANICKI, Piotr K et al.Journal of clinical anesthesia. 2011, Vol 23, Num 4, pp 297-302, issn 0952-8180, 6 p.Article

Prophylaxis of postoperative nausea and vomiting : controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonistsKOVAC, Anthony L.Journal of clinical anesthesia. 2006, Vol 18, Num 4, pp 304-318, issn 0952-8180, 15 p.Article

The neuronal 5-HT₃ receptor network after 20 years of research - : Evolving concepts in management of pain and inflammationFAERBER, Lothar; DRECHSLER, Sabine; LADENBURGER, Stephan et al.European journal of pharmacology. 2007, Vol 560, Num 1, pp 1-8, issn 0014-2999, 8 p.Article

Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1 ]oct-3-yl)-2, 3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT₃ receptor antagonistCAPPELLI, Andrea; TRAVAGLI, Valter; MAKOVEC, Francesco et al.Journal of pharmaceutical sciences. 2006, Vol 95, Num 12, pp 2706-2721, issn 0022-3549, 16 p.Article

Effectiveness of Palonosetron Versus Other Serotonin 5-HT₃ Receptor Antagonists in Triple Antiemetic Regimens During Multiday Highly Emetogenic ChemotherapyKYUNG IM KIM; DONG EUN LEE; CHO, Inhye et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 12, pp 1637-1644, issn 1060-0280, 8 p.Article

Functional characterization of a -100_-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B geneMEINEKE, Cornelia; TZVETKOV, Mladen Vassilev; BOKELMANN, Kristin et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 3, pp 219-230, issn 1744-6872, 12 p.Article

Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjectsBLUM, Robert A; MAJUMDAR, Anup; GOTTESDIENER, Kevin M et al.Clinical therapeutics. 2003, Vol 25, Num 5, pp 1407-1419, issn 0149-2918, 13 p.Article

Tropisetron modulation of the glycine receptor : femtomolar potentiation and a molecular determinant of inhibitionZHE YANG; NEY, Agnieszka; CROMER, Brett A et al.Journal of neurochemistry. 2007, Vol 100, Num 3, pp 758-769, issn 0022-3042, 12 p.Article

Granisetron: relating pharmacology to clinical efficacyBLOWER, Peter R.Supportive care in cancer. 2003, Vol 11, Num 2, pp 93-100, issn 0941-4355, 8 p.Article

Comparative activity of antiemetic drugsJORDAN, Karin; SCHMOLL, Hans J; AAPRO, Matti S et al.Critical reviews in oncology/hematology. 2007, Vol 61, Num 2, pp 162-175, issn 1040-8428, 14 p.Article

5-HT₃-receptor antagonists in the control of delayed-onset emesisGRIDELLI, Cesare.Anticancer research. 2003, Vol 23, Num 3C, pp 2773-2782, issn 0250-7005, 10 p.Article

5-HT₃ receptor blocking activity of arylalkanes isolated from the rhizome of Zingiber officinaleABDEL-AZIZ, H; NAHRSTEDT, A; PETEREIT, F et al.Planta medica. 2005, Vol 71, Num 7, pp 609-616, issn 0032-0943, 8 p.Article

Granisetron: is there a dose-response effect on nausea and vomiting?MINAMI, Masaru.Cancer chemotherapy and pharmacology. 2003, Vol 52, Num 2, pp 89-98, issn 0344-5704, 10 p.Article

Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT₃ receptor antagonist: Results of a phase III, single-dose trial versus dolasetronEISENBERG, Peter; FIGUEROA-VADILLO, Jazmin; ZAMORA, Rosalio et al.Cancer. 2003, Vol 98, Num 11, pp 2473-2482, issn 0008-543X, 10 p.Article

Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonistsPERCIE DU SERT, N; RUDD, J. A; APFEL, C. C et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 3, pp 667-686, issn 0344-5704, 20 p.Article

Beeinflusst die Depressivität den Behandlungseffekt von Tropisetron bei Fibromyalgiepatienten? = The influence of depression on the effect of Tropisetron in the therapy of fibromyalgieSTRATZ, T; VARGA, B; MÜLLER, W et al.Zeitschrift für Rheumatologie (Print). 2003, Vol 62, Num 1, pp 42-45, issn 0340-1855, 4 p.Article

PROPHYLAXIS OF RADIATION-INDUCED NAUSEA AND VOMITING USING 5-HYDROXYTRYPTAMINE-3 SEROTONIN RECEPTOR ANTAGONISTS: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALSSALVO, Nadia; DOBLE, Brett; KHAN, Luluel et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 1, pp 408-417, issn 0360-3016, 10 p.Article

Effects of serotonin 5-HT₃ receptor antagonists on CRF-induced abnormal colonic water transport and defecation in ratsHIRATA, Takuya; KETO, Yoshihiro; NAKATA, Mari et al.European journal of pharmacology. 2008, Vol 587, Num 1-3, pp 281-284, issn 0014-2999, 4 p.Article

Intramuscular injection of granisetron into the masseter muscle increases the pressure pain threshold in healthy participants and patients with localized myalgiaCHRISTIDIS, Nikolaos; NILSSON, Anna; KOPP, Sigvard et al.The Clinical journal of pain. 2007, Vol 23, Num 6, pp 467-472, issn 0749-8047, 6 p.Article

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapyAAPRO, M. S; GRUNBERG, S. M; MACCIOCCHI, A et al.Annals of oncology. 2006, Vol 17, Num 9, pp 1441-1449, issn 0923-7534, 9 p.Article

Synthesis and biological evaluation of a novel structural type of serotonin 5-HT₃ receptor antagonistsRAMACHANDRAN VENKATESHA PERUMAL; MAHESH, Radhakrishnan.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 10, pp 2769-2772, issn 0960-894X, 4 p.Article

5-HT₃-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatmentAAPRO, Matti.Oncology. 2005, Vol 69, Num 2, pp 97-109, issn 0030-2414, 13 p.Article

Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine₃ receptor antagonistsNAVARI, Rudolph M; KOELLER, Jim M.The Annals of pharmacotherapy. 2003, Vol 37, Num 9, pp 1276-1286, issn 1060-0280, 11 p.Article

Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia : A double-blind, randomized, placebo-controlled studyZHANG, Zhang-Jin; KANG, Wan-Hu; QIANG LI et al.Schizophrenia research. 2006, Vol 88, Num 1-3, pp 102-110, issn 0920-9964, 9 p.Article

Efficacy of droperidol in the prevention of cisplatin-induced delayed emesis: a double-blind, randomised parallel studyMINEGISHI, Y; OHMATSU, H; MIYAMOTO, T et al.European journal of cancer (1990). 2004, Vol 40, Num 8, pp 1188-1192, issn 0959-8049, 5 p.Article